Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AH Neuraminidase inhibitors
J05AH04 Laninamivir
D09547 Laninamivir octanoate hydrate (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D09547 Laninamivir octanoate hydrate (JAN)
Drug groups [BR:br08330]
Antiviral
DG03029 Anti-influenza virus agent
DG02842 Neuraminidase inhibitor
DG01201 Laninamivir
D09547 Laninamivir octanoate hydrate
Drug classes [BR:br08332]
Antiviral
DG03029 Anti-influenza virus agent
D09547 Laninamivir octanoate hydrate
Antimicrobials [BR:br08307]
Antivirals
Virus release inhibitor
Neuraminidase inhibitor
D09547 Laninamivir octanoate hydrate (JAN) <JP>
Antimicrobials abbreviations [BR:br08327]
Antivirals
Virus release inhibitor
Neuraminidase inhibitor
D09547 Laninamivir octanoate hydrate (JAN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09547
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09547
Prodrugs [br08324.html]
D09547
Drug groups [BR:br08330]
Antiviral
DG03029 Anti-influenza virus agent
DG02842 Neuraminidase inhibitor
DG01201 Laninamivir